🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Charles River Laboratories International, Inc.

CRL Healthcare
$332.14 $-0.02 (-0.01%)
Market Cap: $15.92 B
Gurus Holding
9
Popularity Rank
#634
% of Shares Held
3.74%
Net Activity (Q3 2026)
-$65.77 M

Guru Ownership Trend

Guru Analysis for Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $594.58 M.

Top institutional holders include John Rogers and Joel Greenblatt.

Institutional sentiment is currently Bearish. This is evidenced by a $65.77 M net outflow during the quarter.

Recent activity highlights Ray Dalio who opened a new position. Conversely, Jefferies Group reduced exposure by 44.6%.

Key Holders

Top 5 by Value

$352.05 M
$121.73 M
$20.81 M
$15.07 M
$13.25 M

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$36.07 M
Total Buy Value
New Buys 2
Additions 1
-$101.84 M
Total Sell Value
Reductions 5
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
6
Net Buyers
3

FAQs for Charles River Laboratories International, Inc. (CRL)

Major holders include John Rogers ($352.05 M), Joel Greenblatt ($121.73 M), Ray Dalio ($20.81 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 1.79 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $65.77 M, with 3 managers increasing positions and 6 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 1 fully exited CRL. The total reported sell value was $101.84 M.

Yes, 2 managers opened new positions in CRL, and 1 increased their existing holdings. The total reported buy value was $36.07 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.66% Reduce -20.8% 1,193,348 $352.05 M Q3 2026
0.24% Reduce -4.7% 412,625 $121.73 M Q3 2026
0.09% New Buy 70,553 $20.81 M Q3 2026
0.00% Add 15.4% 51,153 $15.07 M Q3 2026
0.02% New Buy 44,921 $13.25 M Q3 2026
0.02% Reduce -44.6% 10,121 $2.99 M Q3 2026
0.02% Reduce -9.3% 6,444 $1.9 M Q3 2026
0.00% Reduce -4.7% 955 $281,785 Q3 2026
0.00% 14 $5,265 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form